RxDoctor Payments Data

Jonathon Bird, MD

Family Medicine · Bloomsdale, MONPI 1568457463

Payments from drug & device makers

$2,297in general payments, 2019–2025

Across 119 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$222
  • Lilly USA, LLC$189
  • Amgen$97
  • Abbott$72
  • GSK$70
  • plus $444 from 17 others

What the payments were for

  • Food & beverage$2,297100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,297 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$2,358
Medicare patients
45
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$51,534
MounjaroTirzepatide22$34,091
TrulicityDulaglutide20$33,324
OzempicSemaglutide29$27,490
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$26,889
JanuviaSitagliptin Phosphate18$26,544
NuedextaDextromethorphan Hbr/Quinidine25$19,595
XareltoRivaroxaban18$18,790
JanumetSitagliptin Phos/Metformin Hcl19$14,773
JardianceEmpagliflozin15$14,638
CreonLipase/Protease/Amylase17$13,489
Bydureon BciseExenatide Microspheres13$10,793
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$8,915
FarxigaDapagliflozin Propanediol13$6,843
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$5,170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$189$67,41542 claims
PfizerEliquis$60$51,53463 claims
MerckJanuvia, Janumet$12$41,31737 claims
GSKTrelegy Ellipta, Anoro Ellipta$70$35,80444 claims
Novo NordiskOzempic$222$27,49029 claims
AbbVieCreon$1,204$13,48917 claims
AstraZenecaFarxiga$12$6,84313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Bloomsdale

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →